Can I get Mounjaro for free on the NHS?

NHS access to Mounjaro is real but phased: eligibility thresholds are high and will broaden gradually through 2027.
Scotland, Wales and Northern Ireland operate their own criteria, which differ from NHS England's phased rollout.
Private treatment gives you access without a referral or waiting list, subject to a clinical assessment finding it suitable for you.
Mounjaro is tirzepatide, a Prescription-Only Medicine, no legitimate route to it exists without a prescriber reviewing your health.

Mounjaro is available free on the NHS for some people, but the qualifying criteria are strict and access is being rolled out in phases. Right now, only adults with a BMI of 40 or above and four or more specific weight-related conditions are being brought into NHS treatment. If you don't meet those thresholds — or you'd prefer not to wait — a private prescription from a regulated UK pharmacy is the alternative route. Mounjaro is a Prescription-Only Medicine, so a prescriber must assess your suitability before any treatment begins, whichever route you take.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the NHS rollout works, who qualifies, and what your options are if you don't

You've heard Mounjaro is available on the NHS, here's the reality

A lot of people contact us after reading that Mounjaro is now available through the NHS and assuming they'll be able to get it at their GP surgery. That's understandable. The announcement was significant. But the rollout is phased, and the thresholds at each phase are deliberately narrow to start.

As things stand, the current NHS England cohort covers adults with a BMI of 40 or above who also have four or more qualifying conditions from a specific list: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. Detailed eligibility criteria for Mounjaro explain exactly what counts. From around June 2026, the criteria broaden slightly to include people with a BMI of 35–39.9 with four or more of those same conditions. A further expansion, covering a BMI of 40 or above with three qualifying conditions, is expected around March 2027. For some ethnic backgrounds, BMI thresholds are 2.5 kg/m² lower throughout. NICE's appraisal of tirzepatide (TA1026) sets out the clinical basis for these thresholds.

Even if you meet the numbers, GP participation is optional under the current contract, so your practice may not yet be offering it. And every NHS patient must take part in structured diet and activity support alongside their prescription. Meeting the criteria is necessary, but it isn't sufficient on its own.

What 'free' actually means, and the waiting-list picture

When Mounjaro is prescribed on the NHS, you pay the standard NHS prescription charge (or nothing at all if you're exempt), rather than the full private cost. For people who qualify, that is a meaningful difference. The cost of private treatment is real, and the breakdown of what private Mounjaro costs is worth reading before you decide anything.

The counterpoint is time. NHS pathways for weight-management medicines can carry long waiting lists, especially for the specialist services that many criteria require. From April 2026, GP practices can prescribe directly under the new contract, but as noted above, not every practice has signed up, and capacity is limited. If you sit just below the current BMI or comorbidity threshold, you may be waiting considerably longer than the phase dates suggest.

There's a common misconception worth clearing up gently: some people assume that because Mounjaro is now NICE-recommended, any GP can prescribe it to anyone who asks. NICE recommendation and NHS availability aren't the same thing, and the phased rollout exists precisely because demand far outstrips current NHS capacity.

The private prescription route: who it suits and how it works

Private treatment through a GPhC-registered online pharmacy doesn't require a GP referral or a place on a waiting list. It does require a proper clinical assessment, Mounjaro is a Prescription-Only Medicine, and a prescriber needs to review your health before deciding whether it's right for you. The step-by-step process for getting Mounjaro privately covers what that involves.

The private eligibility criteria follow the licensed indication: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition. That's a considerably broader pool than the current NHS cohort. If you're wondering whether your BMI puts you in range, the BMI requirements for Mounjaro lay it out clearly, and the NHS BMI calculator is a good first check. People with a BMI of 27 can also find out whether they'd be considered based on their overall health picture.

At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber (a real clinician reads your answers) and treatment is dispensed from our own GPhC-registered pharmacy (registration 9012878, verifiable at the GPhC register). If you'd prefer not to have your GP informed, that's also something you can ask about directly, our page on GP notification and privacy explains our approach.

How to find out which route you qualify for

The honest answer is that it depends on your BMI, your existing conditions, and where you live. NHS access in Scotland, Wales and Northern Ireland is governed by different criteria, the NHS England phased rollout doesn't apply across all four nations. If you're in England and your BMI and comorbidities clearly meet the current threshold, approaching your GP is the right first step.

If you're below the NHS threshold, don't want to wait, or want to understand your full picture before deciding, a free private consultation lets a prescriber assess you without obligation. Our weight-loss treatment overview covers both Mounjaro and the other options we offer, including Wegovy, so you can go in with a clear sense of what's available. Speaking to our prescribers doesn't commit you to anything, it just gives you a clearer answer than a search engine can.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions